Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$4.40
+0.200 (+4.76%)
At Close: May 08, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.0858 $8.83 Wednesday, 8th May 2024 ATXI stock ended at $4.40. This is 4.76% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 13.73% from a day low at $4.15 to a day high of $4.72.
90 days $0.0858 $8.83
52 weeks $0.0858 $8.83

Historical Avenue Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 03, 2024 $0.154 $0.158 $0.144 $0.149 737 353
Apr 02, 2024 $0.150 $0.150 $0.142 $0.150 620 604
Apr 01, 2024 $0.154 $0.156 $0.146 $0.150 570 949
Mar 28, 2024 $0.150 $0.157 $0.147 $0.148 790 979
Mar 27, 2024 $0.155 $0.155 $0.148 $0.153 491 034
Mar 26, 2024 $0.155 $0.156 $0.145 $0.151 1 114 784
Mar 25, 2024 $0.149 $0.160 $0.140 $0.155 2 749 859
Mar 22, 2024 $0.148 $0.158 $0.148 $0.151 1 581 698
Mar 21, 2024 $0.162 $0.162 $0.156 $0.158 266 668
Mar 20, 2024 $0.159 $0.167 $0.152 $0.158 860 661
Mar 19, 2024 $0.166 $0.170 $0.157 $0.160 794 433
Mar 18, 2024 $0.160 $0.167 $0.160 $0.160 726 065
Mar 15, 2024 $0.155 $0.175 $0.155 $0.158 2 453 791
Mar 14, 2024 $0.160 $0.163 $0.150 $0.155 1 389 501
Mar 13, 2024 $0.180 $0.183 $0.163 $0.169 1 750 199
Mar 12, 2024 $0.163 $0.185 $0.162 $0.175 2 894 150
Mar 11, 2024 $0.179 $0.179 $0.157 $0.162 3 996 570
Mar 08, 2024 $0.176 $0.200 $0.170 $0.192 5 752 969
Mar 07, 2024 $0.163 $0.175 $0.163 $0.174 1 633 054
Mar 06, 2024 $0.167 $0.180 $0.162 $0.167 2 285 349
Mar 05, 2024 $0.162 $0.169 $0.159 $0.168 2 219 209
Mar 04, 2024 $0.159 $0.167 $0.150 $0.159 2 945 347
Mar 01, 2024 $0.151 $0.160 $0.150 $0.158 998 432
Feb 29, 2024 $0.154 $0.155 $0.146 $0.152 678 748
Feb 28, 2024 $0.152 $0.157 $0.148 $0.152 854 379
Click to get the best stock tips daily for free!

About Avenue Therapeutics, Inc.

Avenue Therapeutics. Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.... ATXI Profile

Golden Star

Ticker Date Change Price
WMT May 06 0.718% $59.87
UNP May 06 2.80% $239.21
JPM May 06 1.90% $192.00
INGR May 03 3.40% $114.56
BNDX May 03 0.247% $48.68
BBCA May 03 0.99% $65.44
ADTH May 03 5.86% $3.24
ASH May 03 1.78% $95.85
INVH May 03 0.90% $34.39
INTU May 03 0.502% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT